With COVID-19 cases surging across Australia, NSW is being spruiked to Korean scientists as a clinical trial hub where drugs can be developed.
After meeting with executives from car giant Hyundai in Seoul to talk investments in hydrogen production, NSW Premier Dominic Perrottet shifted his attention to health as part of his 10-day Asia trade trip.
Australia accounts for 4.2 per cent of all global clinical trials activity last year and the premier wants to pitch NSW as the go-to state for clinical research worldwide.
